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A B S T R A C T
Objectives: To identify clinical features and therapeutic decisions that inﬂuence admission to the
Intensive Care unit (ICU) in children presenting with convulsive status epilepticus (CSE).
Methods: Weevaluated 47 admissionswith status epilepticus to a tertiary paediatric hospital A&E over a
three year period (2003–2006). Following initial management 23 episodes required admission to ICU
and 24 were managed on a paediatric ward. We compared clinical, demographic data and compliance
with our CSE protocol between the ICU and ward groups.
Results: Median age at presentation in the ICU group was 17 months (range 3 months–11 years)
compared to 46 months in the ward group (range 3 months–10 years). Fifty per cent of patients in both
groups had a previous history of seizures. Median duration of pre-hospital seizure activity was 30 min in
both groups. More than two doses of benzodiazepines were given as ﬁrst line medication in 62% of the
ICU group and 33% of the ward group. Among children admitted to ICU with CSE, 26% had beenmanaged
according to the CSE protocol, compared to 66% of childrenwhowere admitted to a hospital ward. Febrile
seizures were the most common aetiology in both groups.
Conclusion: Younger age at presentation, administration of more than two doses of benzodiazepines and
deviation from the CSE protocol appear to be factors which inﬂuence admission of children to ICU.
Recognition of pre-hospital administration of benzodiazepines and adherence to therapeutic guidelines
may reduce the need for ventilatory support in this group.
 2009 Published by Elsevier Ltd on behalf of British Epilepsy Association.
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Convulsive status epilepticus (CSE) is a series of generalised
tonic-clonic seizures without intervening recovery or a continuous
seizure over a period of 30 min. The duration of what deﬁnes a
status epilepticus, in adults and children agedmore than5 years, has
been progressively being reduced from 30min to an operational
deﬁnition of 5 min.1 The concept is the same in both children and
adults. Most seizures stop spontaneously within ﬁve minutes.2
Seizures persisting beyondﬁveminutes have the potential to evolve
into CSE3 and delays in initiating treatment are associated with a
mortality of 14% for young adults (16–59 years) and 38% for elderly
(60 years and above).4 CSE in children has a mortality of 4%5 with
highermorbidity andmortalitywhen there is a delay in treatment.6–
9 Early treatment is therefore a priority.
The causes of CSE in adults4 are different from childhood
CSE. The main causes in adults are low blood concentrations of
antiepileptic drugs (AEDs) in patients with chronic epilepsy (34%),* Corresponding author. Tel.: +00 353 14096413; fax: +00 353 14096887.
E-mail address: david.webb@olchc.ie (D.W. Webb).
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doi:10.1016/j.seizure.2009.07.006remote symptomatic causes (24%), and remaining being acute
symptomatic causes (52%) which include cardiovascular accidents
(22%), anoxia or hypoxia (10%), metabolic causes (10%) and alcohol
withdrawal (10%). In children the singlemain cause of CSE is febrile
convulsion. Many treatment protocols exist due to very few
controlled double-blind clinical studies. In adults and children the
principle is the same with early use of benzodiazepines followed
by a long acting anticonvulsant if convulsive activity continues.
EFNS guidelines10 for adult status epilepticus outlined the
preferred treatment pathway for generalised convulsive status
epilepticus (GCSE) as intravenous (i.v.) administration of 4 mg of
lorazepamor 10 mg of diazepamdirectly followed by 15–18 mg/kg
of phenytoin or equivalent fosphenytoin. If seizures continue for
more than 10 min after ﬁrst injection another 4 mg of lorazepamor
10 mg of diazepam is recommended. Refractory GCSE is treated by
anaesthetic doses of midazolam, propofol or barbiturates; the
anaesthetics are titrated against an electroencephalogram burst
suppression pattern for at least 24 h. In adults thiamine 100 mg IV
and glucose infusions for hypoglycaemia are considered prior to
AED therapy. The main differences in the existing protocols in
adult and paediatric patients are in the sequence of AED therapy
and in the choice of the second line agent. Current AdvancedEpilepsy Association.
Fig. 1. CSE Protocol in our hospital.
Table 1
Comparative data between the ICU and Ward groups.
ICU(n=23) WARD (n=24) p value
Median age 17months* 46 months*
Male to female ratio 9:10 (1:1.1) 10:12 (1:1.2) p>0.05
Previous FS history 5/23 4/24 p>0.05
Known epilepsy 8/23 8/24 p>0.05
Seizure duration (pre-hosp) 30min 30min
Pre-hospital rescue AED 9/23 (39%) 7/24 (29%) p>0.05
Dose pre-hospital (mean) 8.8mg 6.4mg
Ambulance transport 13/23 11/24 p>0.05
Rescue in ambulance 0 0
>2 doses of BZD 15/23 (65%) 8/24 (33%) p<0.05
(0.028)
Early second line AED 12/22 (54%) 9/14 (64%) p=0.31
Compliance with protocol 6/23 (26%) 16/24 (66%) p<0.05
(0.005)
FS: febrile seizure, and BZD: benzodiazepine.
* 3 months–11 years.
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paraldehyde therapy as a second line agent after benzodiazepines
and before phenytoin.
Our protocol for CSE management in children has been in place
since 199811 (Fig. 1). It is similar in principle to the UK Status
Epilepticus Working Party proposed protocol3 and differs from the
APLS guidelines in the use of paraldehyde only. Previous reports
suggest that admission to ICU of children with CSE may be related
to inappropriate management8,12,13 and speciﬁcally to the
excessive use of benzodiazepines.8,13–15 We sought to assess the
factors that inﬂuenced admission to ICU in our cohort.
Our objectives were:
(1) To compare the clinical details, pre-hospital and emergency
hospital management of children with CSE admitted to ICU
(ICU group) with those admitted to the hospital ward (ward
group).
(2) To evaluate the compliance with the hospital CSE protocol in
these two groups and in particular to assess the use of
benzodiazepines and second line AEDs.
(3) To identify factors that may have led to admission to ICU and
suggest strategies to reduce this need.
1.1. Methods
Children presenting between 2003 and 2006 with seizures to
A&E and requiring admission to ICU were identiﬁed through the
hospital ICU database. Only those with conﬁrmed CSE who had
presented to our A&E department were included for analysis.
Twenty-three admissions identiﬁed among 19 children repre-
sented the ICU group. A random selection of children presenting
with CSE presenting to the A&E department, who did not require
admission to ICU, was made from a child neurology database for
the same time period. Twenty-four admissions among 22 children
represented the ward group.
CSE was deﬁned as a generalised tonic-clonic seizure or
multiple seizures without intervening consciousness, lasting
30 min or longer. Patient records were reviewed for clinical anddemographic data including—date of birth, sex, age at presentation
with CSE, background history, seizure history, medication history,
febrile seizure history, associated co-morbidities, mode of trans-
port to hospital, pre-hospital seizure duration, pre-hospital rescue
AEDs, in-hospital AEDs, number of doses of benzodiazepines,
choice and timing of second line agents (phenytoin, or paraldehyde
as in protocol and other e.g. phenobarbitone or midazolam
infusion), ventilation requirement and indication for ICU admis-
sion. Management of the patients was compared to the hospital
protocol (Fig. 1). Admissions that received no more than 2 doses of
benzodiazepines and were administered second line agent if
required within 30 min of arrival were deemed to have been
managed as per protocol. CSE aetiology was classiﬁed as acute
symptomatic, febrile status, remote symptomatic and idiopathic
epilepsy related CSE16 by consensus between the authors.
2. Results
The clinical, demographic andmanagement details are outlined
in Table 1.
Fig. 2. Comparison of aetiology in two groups.
Table 2
Comparison of AED use in ICU and ward groups.
First line AED was benzodiazepines
in all admissions
ICU (23) Ward (24)
Two or less doses of BZD 8 16
More than 2 doses of BZD 15 8




Midazolam infusion 2 0
Third line AED ICU (16) Ward (5)





Seizure termination in ward group (n=24).
Sz terminated with ﬁrst line:
 With 2 or less doses of BZD 7
 With addition of 3rd dose 3
Sz terminated with addition of second line
 With addition of PHT 8
 With addition of paraldehyde 1
Sz terminated with addition of 3rd line
 With addition of PHB to PHT 4
 With addition of PHT to paraldehyde 1
Table 4
IPPV use and indication for ICU.
Timing of IPPV in ICU patients n=23 Indication for ICU admission
Before 2nd line AED 6* Respiratory compromise
After the 2nd line AED 7* Respiratory compromise
After 3rd line 7 Refractory status
None 3 Admitted for observation
Sz termination in ICU group n=23
Apparent Sz termination with 1st line 1 (ventilated but no other AED)
Apparent Sz termination with 2nd line: 6 (did not receive 3rd line AED)
Deﬁnite sz termination with 3rd line 3 (observed with no ventilation)
Timing unclear 13 (none had EEG conﬁrmation)
* Of the 13 admitted with respiratory compromise 10 had >2 doses of
benzodiazepines.
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Median age at presentation in the ICU group was 17 months
(range 3 months–11 years) with 70% under three years of age and
46 months (range 3 months–10 years) in the ward group. The
gender ratio was equal. One girl with epilepsy aged two years had
four admissions and another girl had two admissions to ICU.
A previous history of seizures was present in 56% (13/23) of the
ICU group and 50% (12/24) of ward admissions. It was the ﬁrst
seizure in 43% (10/23) in ICU group and 50% (12/24) in ward group.
Median duration of seizures pre-hospital was 30 min in both
groups (range 5 min–2 h). Ambulance transport was used in 56%
(13/23) of the ICU group and 45% (11/24) of the ward group. The
causes of CSE are outlined in Fig. 2.
2.2. Pre-hospital management
Pre-hospital rescue medication was given in 39% (9/23) of the
ICU group and 29% (7/24) of the ward group, all of whom had a
previous seizure history. Four of the ICU and ﬁve of theWard group
with a prior history of seizures did not receive pre-hospital rescue
therapy. Seven of these had a history of febrile seizures. Seven
children who had received the rescue medications did so at home
prior to transfer. No child received rescue medication during
ambulance transfer.
In the ICU group, the dose of pre-hospital rescue therapy ranged
from 5 mg to 15 mg of Diazepam, buccal Midazolam or both (mean
8.8 mg). In the ward group the dose of rescue therapy ranged from
5 mg to 10 mg of Diazepam, buccal Midazolam or both (mean
6.4 mg).
2.3. In-hospital management
The AED usage and seizure termination are outlined in Tables 2
and 3. Indications for ICU admission and timing of ventilation are
outlined in Table 4.
Three or more doses of benzodiazepines were administered in
65% (15/23) of the ICU group and 33% (8/24) of the ward group.
This included pre-hospital benzodiazepine administration. All
those who received pre-hospital rescue medication went on to
receive more than two doses of benzodiazepines. Administration
of a third dose of benzodiazepine resulted in seizure termination in
only 3 of the 23 (13%).
The timing of second choice drug usage was not signiﬁcantly
different between the ICU andWard groups (54% vs 64%). However
the preferred second choice AED was phenytoin in 63% of the ICU
group and 85% of the ward group. Compliance with the protocol
was 26% (6/23) in the ICU group and 66% (16/24) in the ward
group (p = <0.005). Repeated administration of benzodiazepines
appeared to be the predominant factor in non-adherence to the
protocol in both groups.56% (13/23) of patients were admitted to ICU because of
respiratory compromise. 76% (10/13) of these had received >2
doses of benzodiazepines of whom 30% (4/13) had received pre-
hospital benzodiazepines. The remainder were admitted because
of refractory status or for observation.
S. Tirupathi et al. / Seizure 18 (2009) 630–633 6333. Discussion
We set out to identify the clinical features and therapeutic
decisions that might inﬂuence admission to ICU in children
presenting with CSE. In this retrospective study all the children
were admitted through the same accident and emergency
department with an established CSE protocol. We have compared
those childrenwith CSE admitted to ICUwith those admitted to the
ward and found no differences in gender, medical or seizure
history, pre-hospital management or seizure duration. The proﬁle
of aetiological factors was comparable to other studies of
childhood CSE.12,17,18
None of our admissions had receivedmedical treatment of their
CSE during ambulance transfer. This included nine admissions of
children with a prior history of seizures including one with a
previous history of CSE. Given that the median pre-hospital
duration was 30 min this represents an important missed
therapeutic opportunity. We believe there is a role for education
of all ambulance crew in the administration of rescue therapy for
children with CSE particularly as the use of buccal midazolam is
now easier, more effective and sociallymore acceptable than rectal
diazepam.19,20
Pre-hospital rescue therapy for CSE is of proven beneﬁt.21
However most existing guidelines including the APLS and status
epilepticus working party protocol for management of CSE do not
include or consider pre-hospital treatment or seizure duration. In
our study all those who were treated with pre-hospital benzo-
diazepine received at least 3 doses. Only 13% of this group achieved
seizure control conﬁrming previous observations that multiple
doses of benzodiazepines are of limited value in CSE.9,22 Future
guidelines should include pre-hospital treatment to avoid excessive
use of benzodiazepines and its consequences and limit the use of
benzodiazepines to two doses.
The commonest reason for admission to ICU following CSE in
this study was respiratory compromise and this has been observed
in other similar studies.8,14,15 Children admitted to ICU were more
likely to have received more than two doses of a benzodiazepine
and 70% of children admitted to ICU in our study were less than
three years of age. Our data suggests that children under three
years appear to be at more risk of respiratory compromise from
benzodiazepine overuse.
Current guidelines with two arms contribute to the excessive
use of benzodiazepines and should perhaps be conﬁned to a single
pathway. Furthermore the guidelines fail to take into account the
pre-hospital seizure duration.
The current trend to shorten the deﬁnition of CSEwould suggest
that we should be considering second line agents earlier. In our
opinion intravenous phenytoin should be given without delay to
any child who has been convulsing for 20 min even if this has been
in the pre-hospital setting.
4. Conclusions
Consideration should be given to education of ambulance crews
in the use of rescue therapy for CSE. Young children in particular
with CSE who receive more than two doses of benzodiazepines are
at high risk of requiring assisted ventilation and intensive care. In-
hospital guidelines for management of CSE should take intoconsideration pre-hospital administration of benzodiazepines and
seizure duration. We believe intravenous phenytoin should be
given to all children when seizure activity lasts 20 min or more
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